HOWL (Werewolf Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on HOWL (Werewolf Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

HOWL

Werewolf Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Werewolf Therapeutics Presents Data Expanding Its PREDATOR® Platform at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Nov 7, 2025
Werewolf Therapeutics (HOWL) Upgraded to Strong Buy: Here's Why
Oct 23, 2025
Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer
Oct 8, 2025
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
Oct 3, 2025
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
Sep 2, 2025
Werewolf Therapeutics to Participate in the KidneyCAN 7th Annual Kidney Cancer Research Summit
Jul 9, 2025
Werewolf Therapeutics to Participate in the BIO International Convention
Jun 12, 2025
Werewolf Therapeutics (HOWL) Upgraded to Buy: Here's What You Should Know
May 29, 2025

Reviews